Announcement of the top 200 pharmaceutical sales: AZ, Pfizer, Yangtze River...

For Zhejiang Province, a large pharmaceutical province, in the future, it may directly refer to the sales rankings of the products in the province to collect it.

1.

The documents show that in 2020, the “three-in-one” platform for pharmaceutical equipment procurement in Zhejiang Province is generally operating smoothly, and the online procurement, distribution, warehousing and payment of pharmaceuticals are basically normal, which better serves the needs of clinical medication.

Among the top 200 products announced in Zhejiang Province this time, a total of 120 manufacturers are involved; among them, the first in terms of value is Cefoperazone Sodium and Sulbactam Sodium for Injection (1:1) from Pfizer, followed by Australia AstraZeneca Pty Ltd's budesonide suspension, Pfizer's atorvastatin calcium tablets, Sanofi's insulin glargine injection, Hangzhou Merck's sitagliptin tablets, AstraZeneca's succinic acid Metoprolol sustained-release tablets, Nifedipine controlled-release tablets from Bayer Pharmaceuticals, Metformin hydrochloride tablets from Sino-US Shanghai Bristol-Myers Squibb Pharmaceuticals, Omeprazole enteric-coated capsules from Conba Biosciences, Valsartan and Amlodipine from Beijing Novartis Tablets (Ⅰ) and Rivaroxaban tablets from Bayer Pharmaceuticals ranked in the top ten.

From the perspective of the treatment field, the products with a high ranking in the amount of storage are mainly drugs for cardiovascular and cerebrovascular diseases, antibiotics and anti-tumor drugs.

2.

For example, among the top 20 in Zhejiang Province’s ranking of the amount of deposits, there are a total of 9 multinational companies including Pfizer, Australia AstraZeneca Pty Ltd, Sanofi, Merck, AstraZeneca, Bayer, Novartis Pharmaceutical companies, Sino-US Shanghai Squibb Pharmaceutical Co.

Overall, only Conba’s omeprazole enteric-coated capsules, CSPC’s clopidogrel bisulfate tablets and Shenyang Sansheng Pharmaceutical Co.

It is worth noting that the original research drug is replaced by generic drugs quickly and in a large proportion after the patent expires, which is the normalization of the global drug market.

In addition, Pfizer’s atorvastatin calcium tablets and Sino-US Shanghai Squibb Pharmaceuticals Co.

To a certain extent, in some specific varieties, the substitution effect of generic drugs brought by centralized procurement across the country will still take time to be fully realized.

3.

The first batch of national centralized procurement products: atorvastatin, clopidogrel bisulfate tablets, dexmedetomidine hydrochloride injection, irbesartan hydrochlorothiazide tablets, amlodipine besylate tablets, rosuvastatin calcium Tablets, olanzapine tablets, etc.

The second batch of nationally collected varieties: Acarbose tablets, Acarbose capsules, etc.
The third batch of nationally collected varieties: metformin hydrochloride tablets, valsartan capsules, finasteride tablets, celecoxib capsules, omeprazole enteric-coated capsules, etc.
The fourth batch of nationally collected varieties: valsartan and amlodipine tablets (Ⅰ), levofloxacin tablets, gliclazide sustained-release tablets, parecoxib sodium for injection, pantoprazole sodium for injection, ambroxol hydrochloride Injection etc.

Among them, some varieties have achieved an increase in the market share of generic drugs: For example, Yangtze River’s dexmedetomidine hydrochloride injection ranked 26th, but in general, at least in Zhejiang Province, these varieties are still the original drugs.
Big share.

4.
What is the scope of product selection for provincial procurement with quantity?

Two days before the release of the ranking of the amount of goods in the warehouse, Zhejiang Province issued the "Interim Measures for the Centralized Procurement of Pharmaceutical and Medical Consumables in Zhejiang Province (Draft for Comment)" (hereinafter referred to as the "Measures").
There are subtleties worth thinking about at the time point.

The above-mentioned "Measures" show that centralized procurement with a large amount adheres to provincial-level overall planning, provincial-city linkage, and city-level joint.
It is divided into two forms: provincial-level centralized procurement and municipal-level joint centralized procurement with centralized procurement.
County-level procurement is generally not allowed to carry out centralized procurement.
Quantity purchase.

Among them, the scope of medicines is mainly the varieties with large dosage, high price, sufficient competition, and mature clinical use.
It does not include negotiated medicines and centralized procurement of medicines by national organizations; chemical medicines are generally selected from the varieties that have never passed the consistency evaluation of quality and efficacy.
.
Explore the merger of different generic drugs with similar indications or functions and indications to carry out centralized procurement.

Previously, Cyberlan learned that, in general, provincial-level purchases do not require a technical threshold for consistency evaluation.
Basically, they are products that have a relatively large number of companies that have won bids or are listed on the Internet, and take up more medical insurance funds.
Do purchases with quantity.

Therefore, for Zhejiang Province, a major pharmaceutical province, in the future, it may directly refer to the sales rankings of the products in the province to collect them.
This time, the cash flow products released in Zhejiang Province will be directly affected.
Agents of medication structure and trader varieties.

Perhaps, in the future, the collection of varieties within the scope of Zhejiang will be given priority to choose from these 200 varieties.

Note: The original text has been deleted